Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACII: TACTs vs ACTs in Uncomplicated Falciparum Malaria
NCT02453308Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Aug 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of amodiaquine, mefloquine in Malaria, sponsored by University of Oxford. Started Aug 2015; status: completed.
02
Drugs
amodiaquinemefloquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT02453308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453308.